Additionally, ATF3 downregulates CH25H, a critical regulator of T cell trogocytosis and survival, in intra-tumoral cytotoxic T cells, resulting in their decreased viability and compromised anti-tumor immune responses [12]. This evidence concerns the gene ATF3 and neoplasm.